Chairman Scott, Ranking Member Gillibrand to Examine FDA Regulatory Processes, Rare Disease Treatment Delays, and the Need to Improve Patient Access to Innovation
February 26, 2026
February 26, 2026
WASHINGTON, Feb. 26 -- Sen. Kirsten Gillibrand, D-New York, ranking member of the Senate Special Committee on Aging issued the following news release:
* * *
Chairman Scott, Ranking Member Gillibrand to Examine FDA Regulatory Processes, Rare Disease Treatment Delays, and the Need to Improve Patient Access to Innovation
On Thursday, February 26, Chairman Rick Scott and Ranking Member Kirsten Gillibrand will convene a hearing entitled "From Regulator to R . . .
* * *
Chairman Scott, Ranking Member Gillibrand to Examine FDA Regulatory Processes, Rare Disease Treatment Delays, and the Need to Improve Patient Access to Innovation
On Thursday, February 26, Chairman Rick Scott and Ranking Member Kirsten Gillibrand will convene a hearing entitled "From Regulator to R . . .